| FDG-PET/CT in high-risk primary breast cancer—a prospective study of stage migration and clinical impact M Vogsen, JD Jensen, IY Christensen, O Gerke, AMB Jylling, LB Larsen, ... Breast Cancer Research and Treatment 185, 145-153, 2021 | 29 | 2021 |
| A role of FDG-PET/CT for response evaluation in metastatic breast cancer? MG Hildebrandt, M Naghavi-Behzad, M Vogsen Seminars in Nuclear Medicine 52 (5), 520-530, 2022 | 28 | 2022 |
| Response monitoring in metastatic breast Cancer: a prospective study comparing 18F-FDG PET/CT with conventional CT M Vogsen, F Harbo, NM Jakobsen, HJ Nissen, SE Dahlsgaard-Wallenius, ... Journal of Nuclear Medicine 64 (3), 355-361, 2023 | 19 | 2023 |
| Response monitoring in metastatic breast cancer: a comparison of survival times between FDG-PET/CT and CE-CT M Naghavi-Behzad, M Vogsen, RM Vester, MMB Olsen, H Oltmann, ... British Journal of Cancer 126 (9), 1271-1279, 2022 | 17 | 2022 |
| Benefits and harms of implementing [18F]FDG-PET/CT for diagnosing recurrent breast cancer: a prospective clinical study M Vogsen, JD Jensen, O Gerke, AMB Jylling, JT Asmussen, ... EJNMMI research 11, 1-11, 2021 | 17 | 2021 |
| FDG-PET/CT for response monitoring in metastatic breast cancer: the feasibility and benefits of applying PERCIST M Vogsen, JL Bülow, L Ljungstrøm, HR Oltmann, TA Alamdari, ... Diagnostics 11 (4), 723, 2021 | 17 | 2021 |
| FDG-PET/CT for response monitoring in metastatic breast cancer: Today, tomorrow, and beyond MG Hildebrandt, JF Lauridsen, M Vogsen, J Holm, MH Vilstrup, PE Braad, ... Cancers 11 (8), 1190, 2019 | 16 | 2019 |
| Perspective of patients with metastatic breast cancer on electronic access to scan results: mixed methods study C Baun, M Vogsen, MK Nielsen, PF Høilund-Carlsen, MG Hildebrandt Journal of Medical Internet Research 22 (2), e15723, 2020 | 15 | 2020 |
| Heterogeneity and tumor evolution reflected in liquid biopsy in metastatic breast cancer patients: a review S Kavan, TA Kruse, M Vogsen, MG Hildebrandt, M Thomassen Cancer and Metastasis Reviews 41 (2), 433-446, 2022 | 13 | 2022 |
| FDG-PET/CT versus contrast-enhanced CT for response evaluation in metastatic breast cancer: a systematic review F Helland, M Hallin Henriksen, O Gerke, M Vogsen, PF Høilund-Carlsen, ... Diagnostics 9 (3), 106, 2019 | 12 | 2019 |
| Learning from patient involvement in a clinical study analyzing PET/CT in women with advanced breast cancer M Vogsen, S Geneser, ML Rasmussen, M Hørder, MG Hildebrandt Research Involvement and Engagement 6, 1-8, 2020 | 11 | 2020 |
| Interrater agreement and reliability of PERCIST and visual assessment when using 18F-FDG-PET/CT for response monitoring of metastatic breast cancer JS Sørensen, MH Vilstrup, J Holm, M Vogsen, JL Bülow, L Ljungstrøm, ... Diagnostics 10 (12), 1001, 2020 | 11 | 2020 |
| Total thyroidectomy for thyroid cancer followed by thyroid storm due to thyrotropin receptor antibody stimulation of metastatic thyroid tissue L Folkestad, F Brandt, T Brix, M Vogsen, L Bastholt, P Grupe, JK Petersen, ... European Thyroid Journal 6 (5), 276-280, 2017 | 10 | 2017 |
| Clinical impact of FDG-PET/CT compared with CE-CT in response monitoring of metastatic breast cancer M Naghavi-Behzad, HR Oltmann, TA Alamdari, JL Bülow, L Ljungstrøm, ... Cancers 13 (16), 4080, 2021 | 9 | 2021 |
| 2-[18F]FDG-PET/CT is a better predictor of survival than conventional CT: a prospective study of response monitoring in metastatic breast cancer M Vogsen, M Naghavi-Behzad, FG Harbo, NM Jakobsen, O Gerke, ... Scientific Reports 13 (1), 5552, 2023 | 8 | 2023 |
| Adherence to treatment guidelines and survival in older women with early-stage breast cancer in Denmark 2008–2012 M Vogsen, C Bille, AMB Jylling, MB Jensen, M Ewertz, ... Acta Oncologica 59 (7), 741-747, 2020 | 6 | 2020 |
| Prognostic Value of Dual-Time-Point 18F-Fluorodeoxyglucose PET/CT in Metastatic Breast Cancer: An Exploratory Study of Quantitative Measures M Naghavi-Behzad, C Bjerg Petersen, M Vogsen, PE Braad, ... Diagnostics 10 (6), 398, 2020 | 3 | 2020 |
| Comparison of Image Quality and Quantification Parameters between Q. Clear and OSEM Reconstruction Methods on FDG-PET/CT Images in Patients with Metastatic Breast Cancer M Naghavi-Behzad, M Vogsen, O Gerke, SE Dahlsgaard-Wallenius, ... Journal of imaging 9 (3), 65, 2023 | 2 | 2023 |
| Effect of capecitabine as monotherapy for HER2 normal metastatic breast cancer ADM Knudsen, MW Modvig, M Vogsen, AR Kodahl Medical Oncology 41 (5), 99, 2024 | 1 | 2024 |
| The Pattern of Metastatic Breast Cancer: A Prospective Head-to-Head Comparison of [18F]FDG-PET/CT and CE-CT R Gram-Nielsen, IY Christensen, M Naghavi-Behzad, ... Journal of Imaging 9 (10), 222, 2023 | 1 | 2023 |
Malene Grubbe HildebrandtDepartment of Nuclear Medicine, Odense University Hospital在 rsyd.dk 的电子邮件经过验证
